Axcynsis Pipeline
Target | Indication | Discovery | Optimization | IND-enabling | Clinical Trials | |
---|---|---|---|---|---|---|
T² – 01 | Undisclosed | Liquid and Solid Tumour | ||||
T² – 03 | Undisclosed | Solid Tumour | ||||
T² – 04 | Undisclosed | Solid Tumour | ||||
T² – 00 | Undisclosed | Undisclosed |
Target | Indication | Discovery | Optimization | IND-enabling | Clinical Trials | |
---|---|---|---|---|---|---|
T² – 01 | Undisclosed | Liquid and Solid Tumour | ||||
T² – 03 | Undisclosed | Solid Tumour | ||||
T² – 04 | Undisclosed | Solid Tumour | ||||
T² – 00 | Undisclosed | Undisclosed |